Alpha Teknova (TKNO) Cash from Operations (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Cash from Operations of 3359000.0 for Q1 2026, up 18.13% year-over-year from 2843403.55 in Q1 2025, and down 627.06% quarter-over-quarter from 462000.0 in Q4 2025.
Alpha Teknova (TKNO) Cash from Operations (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Cash from Operations for 7 consecutive years, with 3359000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 18.13% year-over-year to 3359000.0; the TTM figure through Mar 2026 stood at 7902000.0 (up 20.47% YoY), while the FY2025 annual figure was 8646000.0, up 30.22% from the prior year.
- Cash from Operations eased to 3359000.0 in Q1 2026 per TKNO's latest filing, from 462000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 462000.0 in Q4 2025 and bottomed at 8332000.0 in Q3 2022.
- Historically, Cash from Operations has averaged 4153529.41 across 5 years, with a median of 3856000.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 316.62% — and 2024, when it surged 67.63%.
- Alpha Teknova's Cash from Operations stood at 8029000.0 in 2022, then jumped by 63.98% to 2892000.0 in 2023, then soared by 67.63% to 936000.0 in 2024, then soared by 50.64% to 462000.0 in 2025, then tumbled by 627.06% to 3359000.0 in 2026.
- Business Quant data shows TKNO's Cash from Operations at 3359000.0 in Q1 2026, 462000.0 in Q4 2025, and 1980000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.59 Bn | 30.92 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - | - |
| 10 | Alpha Teknova | 384.03 Mn | 366.59 Mn | 4.89 Mn | -471,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -471,000.00 |
| Jun 30, 2026 | -471,000.00 |
| Mar 31, 2026 | -3.36 Mn |
| Mar 31, 2026 | -3.36 Mn |
| Dec 31, 2025 | -462,000.00 |
| Dec 31, 2025 | -462,000.00 |
| Sep 30, 2025 | -1.98 Mn |
| Sep 30, 2025 | -1.98 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Mar 31, 2025 | -4.10 Mn |
| Mar 31, 2025 | -4.10 Mn |
| Dec 31, 2024 | -936,000.00 |
| Dec 31, 2024 | -936,000.00 |
| Sep 30, 2024 | -2.06 Mn |
| Sep 30, 2024 | -2.06 Mn |
| Jun 30, 2024 | -2.84 Mn |
| Jun 30, 2024 | -2.84 Mn |
| Mar 31, 2024 | -6.56 Mn |
| Mar 31, 2024 | -6.56 Mn |